IMMUNOVEC
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system. Its gene therapy is intended for hematopoietic diseases.
IMMUNOVEC
Industry:
Biotechnology Genetics Health Care Medical
Founded:
2019-01-01
Address:
Santa Monica, California, United States
Country:
United States
Website Url:
http://www.immunovec.com
Status:
Active
Total Funding:
4.3 M USD
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Cure Forward
Cure Forward helps cancer patients and physicians access advanced treatments in oncology.
DalCor Pharmaceuticals
DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
KayoThera
KayoThera develops therapeutics used to cure late-stage and metastatic cancers.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Current Employees Featured
Founder
Official Site Inspections
http://www.immunovec.com
- Host name: sites.framer.app
- IP address: 31.43.160.6
- Location: Makiyivka Ukraine
- Latitude: 48.0478
- Longitude: 37.9258
- Timezone: Europe/Kiev
- Postal: 20754
